Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial

Peer Review reports

Original Submission
26 Feb 2013	Submitted	Original manuscript
2 Apr 2013	Reviewed	Reviewer Report - Jun-ichi Kira
3 Apr 2013	Reviewed	Reviewer Report - Houshang Rafatpanah
22 Apr 2013	Reviewed	Reviewer Report - George Zhang
4 May 2013	Author responded	Author comments - Tatsufumi Nakamura
Resubmission - Version 2
4 May 2013	Submitted	Manuscript version 2
15 May 2013	Reviewed	Reviewer Report - George Zhang
22 May 2013	Reviewed	Reviewer Report - Houshang Rafatpanah
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
30 May 2013	Editorially accepted
15 Aug 2013	Article published	10.1186/1741-7015-11-182

Back to article page